Point-of-care diagnostic platform that confirms UTI infection and indicates antibiotic sensitivity within one hour.
JIDDU is a clinical diagnostics platform developed by Astek Diagnostics that detects and confirms urinary tract infections and indicates appropriate antibiotic sensitivity within one hour. It addresses the critical gap where standard urine cultures take days and often lead to incorrect prescriptions. The platform detects bacterial oxygen consumption to enable evidence-based, point-of-care antibiotic treatment decisions. Astek is partnered with the University of Maryland Medical Center and MedStar Health, targeting a 2025 market entry. JIDDU is a product of Astek Diagnostics.